机构:[1]Department of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China.[2]Department of Obstetrics and Gynecology, The First Hospital of Affiliated to Army Medical University, Chongqing, China.[3]Gynecological Cancer Center, Chongqing University Cancer Hospital, Chongqing Cancer Research Institute, Chongqing Cancer Hospital, Chongqing, China.
第一作者机构:[1]Department of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China.[2]Department of Obstetrics and Gynecology, The First Hospital of Affiliated to Army Medical University, Chongqing, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yu Meijia,Zhang Qin,Zhao Xia.Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review[J].Frontiers in oncology.2022,12:973077.doi:10.3389/fonc.2022.973077.
APA:
Yu Meijia,Zhang Qin&Zhao Xia.(2022).Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review.Frontiers in oncology,12,
MLA:
Yu Meijia,et al."Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review".Frontiers in oncology 12.(2022):973077